HCCA advocates for a consumer-centred health care system where

  • everyone has access to the information and services they need
  • health services are safe and high quality
  • consumers play a role in improving the health care system

We achieve this by working closely with people, organisations, service providers and government.


HCCA develops policies and contributes to health policy discussions through a number of avenues:


Priority policy areas from our Strategic Plan 2014-2017 are:

  • Quality and safety of health care
  • Primary health care
  • Self-management of chronic conditions
  • Aged care
  • Out of pocket cost of health care for consumers


We aim for all HCCA health issues policies to be:

  • Evidence-based
  • Inclusive of the diversity of consumer views
  • To provide policy leadership and a strong 'consumer perspective' in relevant public policy debates
  • With oversight from our membership through representation on the Health Policy Steering Committee
  • High quality, measured by an evaluation framework for ensuring the quality of HCCA policy development outputs is developed and modified


Consumers Health Forum of Australia








Health Consumers NSW










Health Consumers QLD












Health Consumers Alliance of SA











Health Issues Centre VIC








Health Consumers' Council WA







Check back here soon for more policy input opportunities!


What Who How


HCCA would like to keep you up-to-date to what's happening in the world of consumer advocacy. This page gives you a run down of newly completed profects and those of our colleagues around Australia and the world.




Involving Health Consumers in Health and Medical Research


Health Consumers NSW have released a report entitled 'Involving Health Consumers in Health and Medical Research: Enablers and Challenges from a Consumer Perspective'. It is a joint project with Research4Me. The report outlines:

  • types of research consumers are involved in
  • what helps support consumer involvement in research
  • how consumers can add value to clinical trials.